Africa-Press – Eswatini. Thembinkhosi Dlamini,the Executive Director of the Coordinating Assembly of Non-Governmental Organizations(CANGO) has confirmed that, eSwatini is among the first countries receiving global support to implement the anti-HIV injection program.
Responding to the Executive Director said, “CANGO is one of the Principal Recipients of Global Fund grants in Eswatini implementing HIV prevention programs targeting high risk populations as defined by the National HIV Strategic Framework targeting high risk populations including adolescents and young women, adolescent boys and young men, key populations in selected target Tinkhundla and tertiary institutions in the country”.
Dlamini said, the Global Fund and Gilead Sciences have entered into a strategic partnership to accelerate access to Lenacapavir, a groundbreaking long-acting injectable PrEP(pre-exposure prophylaxis) for HIV prevention.
“Gilead has pledged to supply Lenacapavir at no profit in high incidence, resource limited settings until licensed generics can fully meet demand hence projected that access to Lenacapavir will be available to populations that would not have had the access to this breakthough option. Eswatini through the Ministry of Health has adopted the breakthrough option of the LEN PrEP and Global Fund committed ~$660k for the procurement of the commodity through NERCHA,” said the Executive Director.
For More News And Analysis About Eswatini Follow Africa-Press
